Today: 15 May 2026
American Express stock price slips after Q4 results: dividend hike, spending and rate-cap risk in focus
31 January 2026
2 mins read

American Express stock price slips after Q4 results: dividend hike, spending and rate-cap risk in focus

New York, January 30, 2026, 19:23 (EST) — Trading continues after hours.

  • American Express shares fell 1.8% by Friday’s close, with after-hours trading hovering close to that level.
  • The card issuer forecasted 2026 EPS between $17.30 and $17.90, with revenue expected to rise 9% to 10%.
  • Investors are balancing the expense of updating premium cards with steady travel and dining spending.

American Express Company shares ended Friday down 1.8% at $352.17 and showed little movement in after-hours trading. The decline followed the release of the company’s fourth-quarter results and its 2026 targets.

The numbers matter because the card business has become a real-time gauge of consumer resilience, particularly among wealthier customers. American Express relies heavily on affluent users, so its spending trends often appear stronger than the wider retail landscape.

Behind the scenes, costs are mounting. The company’s premium-card overhaul has driven up rewards and marketing expenses, with returns that don’t always show up right away.

For the quarter ending Dec. 31, revenue net of interest expense climbed 10% to $18.98 billion. Diluted earnings came in at $3.53 per share. Billed business, a stand-in for card spending, increased 9% to $445.1 billion. Expenses rose 10% to $14.5 billion. Provisions for credit losses—funds set aside for bad loans—jumped to $1.4 billion, as the net write-off rate edged up to 2.1%. Stephen J. Squeri said the company anticipates 2026 revenue growth between 9% and 10%, with earnings per share expected at $17.30 to $17.90. The quarterly dividend is set to rise roughly 16%, reaching $0.95.

Christophe Le Caillec noted that spending on the company’s cards by Gen Z and millennials has surpassed that of Gen X in the U.S. consumer segment. “We’re not projecting any discontinuity,” he added, highlighting steady demand in travel, dining, and luxury sectors. Meanwhile, Truist Financial analysts pointed out that the cost of the Platinum card refresh is hitting this quarter, ahead of a clearer rise in new accounts. Reuters

Cardholder spending jumped to $506.2 billion this quarter, up from $464 billion a year ago, while outstanding card loans increased to $213 billion from $199.1 billion, the company disclosed to the Associated Press. The U.S. Platinum refresh raised the annual fee to $895 and introduced perks like a $400 dining credit. AmEx also noted that younger customers are making up a larger share of the spending mix.

The selloff extended beyond AmEx. Visa’s shares dropped on Friday as well, with both stocks ranking among the largest drags on the Dow Jones Industrial Average that day.

Policy risks loom over the entire group. Donald Trump has proposed a one-year cap limiting credit-card interest rates to 10%, which would need congressional approval. On the earnings call, Squeri dismissed the 10% cap as “not the answer.” Analysts at William Blair noted AmEx’s premium clientele might soften the blow compared to the broader industry but highlighted significant uncertainty about how such a rule would be enforced. American Banker

U.S. cash markets remain closed until Monday, Feb. 2, leaving traders to watch for follow-through. The key question: will broker notes emphasize the rising expense run-rate or highlight steady spending? Credit trends will also stay in focus as loan balances continue to climb.

American Express will report first-quarter results on April 24. Investors will watch to see if the costly premium-card revamp is driving new sign-ups and if credit losses remain under control.

Stock Market Today

  • SpaceX Sets June 11 for IPO Pricing on Nasdaq
    May 15, 2026, 3:44 PM EDT. SpaceX, Elon Musk's aerospace company, aims to price its initial public offering (IPO) on June 11, according to sources. The firm has chosen Nasdaq as its listing exchange. This move accelerates expectations for the aerospace giant's entry into public markets, potentially making it one of the biggest IPOs in the sector. The listing will allow investors to buy shares in the company known for its rocket launches and satellite technology, marking a significant milestone in SpaceX's financial journey.

Latest articles

AT&T, Verizon, T-Mobile Rally Against Dead Zones With Uncommon Satellite Move, Eye Starlink Push

AT&T, Verizon, T-Mobile Rally Against Dead Zones With Uncommon Satellite Move, Eye Starlink Push

15 May 2026
AT&T, Verizon, and T-Mobile announced plans to jointly build a satellite-based network to eliminate U.S. wireless dead zones, aiming to connect ordinary phones directly to satellites. The move follows the FCC’s approval of EchoStar’s $40 billion spectrum sale to SpaceX and AT&T. The carriers have an agreement in principle but have not finalized terms. AT&T reported $31.5 billion in Q1 revenue and $126.4 billion in net debt.
Ambev Stock Faces Reality Check After Brazil Beer Boom and UBS Sell Call

Ambev Stock Faces Reality Check After Brazil Beer Boom and UBS Sell Call

15 May 2026
Ambev’s São Paulo shares fell 0.25% to 15.73 reais Friday, despite UBS raising its target price but maintaining a Sell rating. First-quarter profit rose 2.1% to 3.89 billion reais, with Brazil Beer volumes hitting a record and net revenue up 9.6%. Cash flow surged 162.5% to 3.16 billion reais. Consolidated cash cost of goods sold per hectoliter climbed 8.5%.
Pfizer Inc Looks to India for Growth—But Proof Remains Elusive for Investors

Pfizer Inc Looks to India for Growth—But Proof Remains Elusive for Investors

15 May 2026
Pfizer is increasing investment in India for cancer drugs, obesity treatments, and vaccines as it seeks growth beyond COVID-era sales. The company reported Q1 revenue of $14.5 billion, up 5%, but expects a $1.5 billion hit this year from generic competition. Shares fell 1.8% to $25.29 in New York trading. In Europe, Pfizer won expanded approval for its hemophilia drug Hympavzi.
BigBear.ai Stock Drops as Investors Question Defense-AI Growth

BigBear.ai Stock Drops as Investors Question Defense-AI Growth

15 May 2026
BigBear.ai shares fell about 5% to $4.16 Friday afternoon after reporting flat first-quarter revenue of $34.4 million and a wider adjusted EBITDA loss of $9.9 million. Backlog rose 14% to $281.9 million, boosted by a $53 million classified contract. The company kept its 2026 revenue forecast at $135 million to $165 million. Gross margin improved to 34.0% from 21.3% a year earlier.
Salesforce stock steadies after-hours, but AI anxiety keeps CRM in focus for Monday
Previous Story

Salesforce stock steadies after-hours, but AI anxiety keeps CRM in focus for Monday

Disney stock heads into new week with Iger succession report hanging over DIS shares
Next Story

Disney stock heads into new week with Iger succession report hanging over DIS shares

Go toTop